t
Dechra Pharmaceuticals PLC announced on September 15, 2022, an updated mailing date for its 2022 Annual Report and Accounts to registered shareholders. The Company now expects to mail these documents on September 20, 2022, instead of the previously announced September 19, 2022, as the latter is a UK Bank Holiday. A copy of these documents will also be submitted to the National Storage Mechanism on September 20, 2022, in accordance with Listing Rule 9.6.1.
| Date | 15 Sept 2022 |
| Time | 15:28:44 |
| Category | Results |
| ID | 6544Z |
Thursday, 15 September 2022
Dechra® Pharmaceuticals PLC
(the Company)
2022 Annual Report Posting Date
The Company announced last week (on 6 September) that the 2022 Annual Report and Accounts and related documents would be mailed to registered shareholders on the Monday, 19 September 2022. However, as this day is being marked as a Bank Holiday in the UK, the Company wishes to advise shareholders that we now expect to mail all documentation on Tuesday 20 September 2022.
At the same time, and in accordance with Listing Rule 9.6.1 a copy of all these documents will be submitted to the National Storage Mechanism and will be available for viewing.
The 2022 Annual Report and Accounts is already available to view and download from the Company's investor website.
For further information, please contact:
Melanie Hall, Company Secretary
Dechra Pharmaceuticals PLC
Telephone: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.
For more information please visit: www.dechra.com
LEI: 213800J4UVB5OWG8VX82
Trademarks
Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.